Terminated, withdrawn and suspended trials

clinicaltrialsObservedShowing 401–450 of 876 studies, most recently updated first

NCT	Title	Phase	Status	First posted	Lead sponsor	Why stopped (as posted)	Category
NCT04403568	Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular…	Early Phase 1	withdrawn	May 27, 2020	The University of Texas Health Science Center at San Antonio	No subjects were enrolled in this study, the PI will seek funding and revise the protocol for…	Enrollment / accrual
NCT01805037	Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+…	Phase 1 / Phase 2	terminated	Mar 5, 2013	Northwestern University	Lack of funding	Funding
NCT03545165	177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC	Phase 1 / Phase 2	terminated	Jun 4, 2018	Weill Medical College of Cornell University	Sponsor withdrawal	Other (stated, no rule matched)
NCT04296578	Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant…	Phase 1	withdrawn	Mar 5, 2020	Stanford University	Study did not start	Other (stated, no rule matched)
NCT02985021	Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies	Phase 2	terminated	Dec 7, 2016	Seattle Institute for Biomedical and Clinical Research	Competing studies	Other (stated, no rule matched)
NCT03829930	Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer	Phase 1	terminated	Feb 4, 2019	George Washington University	Sponsor discontinued the drug	Other (stated, no rule matched)
NCT02108613	Living Well on Androgen Deprivation Therapy	N/A	withdrawn	Apr 9, 2014	British Columbia Cancer Agency	It was deemed not enough funding and the initial funding returned and study withdrawn (never opened…	Enrollment / accrual
NCT00911079	Pilot Study of a Catheter-based Ultrasound Hyperthermia System	N/A	terminated	Jun 1, 2009	University of California, San Francisco	Low Accrual	Enrollment / accrual
NCT02432820	Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate…	—	terminated	May 4, 2015	Stanford University	Business decision	Sponsor / business decision
NCT04486846	Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)	N/A	withdrawn	Jul 27, 2020	Duke University	Principal Investigator left Duke University	Investigator
NCT03927924	High-intensity Focused Ultrasound Study	N/A	terminated	Apr 25, 2019	Chinese University of Hong Kong	due to funding	Funding
NCT03532308	Nutrition and Prostate Cancer	Phase 3	terminated	May 22, 2018	Yale University	Unable to meet recruitment goals.	Enrollment / accrual
NCT01802307	Focal Therapy for Prostate Cancer	Phase 2	withdrawn	Mar 1, 2013	University of Maryland, Baltimore	Study was withdrawn	Other (stated, no rule matched)
NCT02805894	NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate…	Phase 1 / Phase 2	terminated	Jun 20, 2016	Nanobiotix	Prostate cancer treatment has greatly changed since the initiation of this trial and therefore we…	Other (stated, no rule matched)
NCT03478904	Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose…	Phase 1	terminated	Mar 27, 2018	National Cancer Institute (NCI)	Study drug is now commercially available in tablet format	Other (stated, no rule matched)
NCT01566045	MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate…	N/A	withdrawn	Mar 29, 2012	Philips Healthcare	not stated	Not stated
NCT00621413	Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam…	—	withdrawn	Feb 22, 2008	IsoRay Medical, Inc.	Study never moved forward due to no accrual	Enrollment / accrual
NCT02497638	LIpitor and biGuanide to Androgen Delay Trial(LIGAND)	Phase 2	withdrawn	Jul 14, 2015	University Health Network, Toronto	Drug intervention no longer relevant for the proposed population	Other (stated, no rule matched)
NCT02685267	Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant…(Doce/Enza)	Phase 2	terminated	Feb 18, 2016	Prostate Cancer Clinical Trials Consortium	not stated	Not stated
NCT00991315	Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing…	—	terminated	Oct 8, 2009	Rutgers, The State University of New Jersey	Specimens are now collected through the BRS protocol.	Other (stated, no rule matched)
NCT02853097	Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients	—	terminated	Aug 2, 2016	University of Southern California	Slow accrual	Enrollment / accrual
NCT01376661	Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An…	—	terminated	Jun 20, 2011	St. Joseph Hospital of Orange	Early termination due to PI's decision to discontinue research activities.	Other (stated, no rule matched)
NCT01678443	Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With…	Phase 1	terminated	Sep 5, 2012	Fred Hutchinson Cancer Center	Terminated due to low accrual.	Enrollment / accrual
NCT03589781	Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of…	N/A	withdrawn	Jul 18, 2018	Nikkei (Canada) Marketing Limited	Covid 19 Pandemic - Unable to enroll patients	COVID-19 / pandemic
NCT03042312	Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy(RESIST-PC)	Phase 2	terminated	Feb 3, 2017	Endocyte	Recruitment was stopped before the target sample size was achieved.	Enrollment / accrual
NCT04305379	Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical…(BLANKET)	N/A	terminated	Mar 12, 2020	Johns Hopkins University	Stopped due to COVID-19 pandemic, low priority among initiatives and officially terminated.	COVID-19 / pandemic
NCT02295163	Stellate Ganglion Block for Hot Flushes in Men Treated With ADT	N/A	withdrawn	Nov 20, 2014	Rijnstate Hospital	no participants	Other (stated, no rule matched)
NCT03572478	Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer	Phase 1 / Phase 2	terminated	Jun 28, 2018	University of Chicago	The study was terminated due to lack of efficacy.	Efficacy / futility
NCT01717677	Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early…(PREFERE)	N/A	terminated	Oct 30, 2012	Association of Urologic Oncology (AUO)	Insufficient Recruitment	Enrollment / accrual
NCT03261336	Oral Calcitriol With Ketoconazole in CRPC	Phase 2	terminated	Aug 25, 2017	Donald Trump, MD	can not meet enrollment	Enrollment / accrual
NCT03741712	A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC	Phase 1 / Phase 2	terminated	Nov 15, 2018	Jiangsu HengRui Medicine Co., Ltd.	According to the available data from the trial，the sponsor determined to terminate this study.	Other (stated, no rule matched)
NCT03514836	A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic…	Phase 1 / Phase 2	terminated	May 2, 2018	SOTIO a.s.	insufficient accrual	Enrollment / accrual
NCT02698176	A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced…	Phase 1	terminated	Mar 3, 2016	Merck Sharp & Dohme LLC	This study was terminated due to limited efficacy and not due to safety reasons.	Safety / toxicity
NCT02844582	Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant…	Phase 2	terminated	Jul 26, 2016	University of California, Davis	Poor accrual of subjects onto study	Enrollment / accrual
NCT04585932	Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the…	Phase 2	withdrawn	Oct 14, 2020	M.D. Anderson Cancer Center	At the request of the ad interim Department Chairman due to PI is no longer at institution.	Other (stated, no rule matched)
NCT03327662	Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer(CTC-STOP)	Phase 3	terminated	Oct 31, 2017	Institute of Cancer Research, United Kingdom	Underrecruitment	Other (stated, no rule matched)
NCT00757757	A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone…	Phase 1 / Phase 2	terminated	Sep 23, 2008	Novartis Pharmaceuticals	not stated	Not stated
NCT04027270	Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients…	N/A	withdrawn	Jul 19, 2019	University of Missouri-Columbia	Covid	COVID-19 / pandemic
NCT03563352	Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in…	—	withdrawn	Jun 20, 2018	University of Southern California	Zero accrual	Enrollment / accrual
NCT00058188	Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen…	Phase 3	terminated	Apr 9, 2003	Northwestern University	Closed by the research committee	Other (stated, no rule matched)
NCT00780975	A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer	Phase 2	terminated	Oct 28, 2008	PharmaMar	Poor recruitment	Enrollment / accrual
NCT03308734	Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients…	N/A	withdrawn	Oct 13, 2017	University of Bath	Lack of resource from collaborating organisation	Other (stated, no rule matched)
NCT01691976	Mild Cognitive Impairment in Men Following Androgen Deprivation	N/A	withdrawn	Sep 25, 2012	Imperial College London	No one recruited due to resource limitations. Issues with how complicated the study could be for…	Enrollment / accrual
NCT04225299	Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk…	Phase 3	withdrawn	Jan 13, 2020	Steba Biotech S.A.	FDA didn't approve the design of the protocol so we didn't start the study	Other (stated, no rule matched)
NCT04399824	Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer	N/A	withdrawn	May 22, 2020	Jonsson Comprehensive Cancer Center	Study did not open	Other (stated, no rule matched)
NCT04266262	High-Intensity Training for Men With Prostate Cancer on Active Surveillance: A…	N/A	terminated	Feb 12, 2020	University of Toronto	All research activities were suspended as a result of COVID-19.	COVID-19 / pandemic
NCT03724253	[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin…(NeoFIND)	Phase 2	terminated	Oct 30, 2018	Advanced Accelerator Applications	Recruitment was stopped before the target sample size was achieved.	Enrollment / accrual
NCT01928485	Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer	Phase 2	terminated	Aug 26, 2013	Sanjay Gupta PhD	Slow Accrual	Enrollment / accrual
NCT02006927	A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote…	N/A	terminated	Dec 10, 2013	Kenneth M Peters, MD	Lack of Enrollment	Enrollment / accrual
NCT00004026	CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to…	Phase 2	terminated	Aug 27, 2004	CTI BioPharma	not stated	Not stated

Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.

Data updated 23 days agoSource updated Sep 16, 2021source: clinicaltrials

Terminated, withdrawn and suspended studies

Stated reasons by category

Classification rules